Skip to main content
European Commission logo print header

Cell and gene therapy based approaches for treatment of Parkinson's disease: from models to clinics

Cel

Parkinson s disease is one of the common causes of disability in the aging population, representing a major health problem for the affected individuals and a socioeconomic burden to the society. In the present proposal, the applicant puts forward an ambitious but feasible program to tackle a number of significant issues that remain unsolved in the field. He combines his strong track record in animal models of Parkinson s disease and novel cell and gene therapy-based therapeutic strategies with powerful bio-imaging techniques in order to make bold steps towards translation of new and better treatments to patients suffering from this illness. He does so in a manner that combines, on one hand, the strength of clearly-defined hypotheses and well-established tools for results towards clinical translation, with high-risk high-reward projects that hold the potential to yield ground-breaking discoveries in implementation of novel imaging techniques, on the other.

Zaproszenie do składania wniosków

ERC-2009-StG
Zobacz inne projekty w ramach tego zaproszenia

System finansowania

ERC-SG - ERC Starting Grant

Instytucja przyjmująca

MAX IV Laboratory, Lund University
Wkład UE
€ 1 508 940,00
Adres
Paradisgatan 5c
22100 LUND
Szwecja

Zobacz na mapie

Region
Södra Sverige Sydsverige Skåne län
Rodzaj działalności
Higher or Secondary Education Establishments
Kierownik naukowy
Deniz Kirik (Prof.)
Kontakt administracyjny
Deniz Kirik (Prof.)
Linki
Koszt całkowity
Brak danych

Beneficjenci (1)